How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/muscle-spasticity-of-cerebral-origin.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Muscle Spasticity of Cerebral Origin — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Muscle Spasticity of Cerebral Origin (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Muscle Spasticity of Cerebral Origin, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Zanaflex	TIZANIDINE	Legacy Pharma Usa	Central alpha-2 Adrenergic Agonist	Nischarin		1996-01-01
Ryanodex	DANTROLENE	Ph Health	Skeletal Muscle Relaxant	Ryanodine receptor 1		1974-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Muscle Spasticity of Cerebral Origin
Legacy Pharma Usa · 1 drug in Muscle Spasticity of Cerebral Origin
Ph Health · 1 drug in Muscle Spasticity of Cerebral Origin

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Muscle Spasticity of Cerebral Origin:

Cite this brief

Drug Landscape (2026). Muscle Spasticity of Cerebral Origin — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/muscle-spasticity-of-cerebral-origin. Accessed 2026-06-10.

Muscle Spasticity of Cerebral Origin full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing